| Wilbert B. Maniego, M.d., P.c. | |
|
915 Hillside Ave New Hyde Park NY 11040-2529 | |
| (718) 343-7600 | |
| (718) 343-7603 |
| Full Name | Wilbert B. Maniego, M.d., P.c. |
|---|---|
| Speciality | Internal Medicine |
| Location | 915 Hillside Ave, New Hyde Park, New York |
| Authorized Official Name and Position | Wilbert B Maniego (PRESIDENT/PHYSICIAN) |
| Authorized Official Contact | 7183437600 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Wilbert B. Maniego, M.d., P.c. 915 Hillside Ave New Hyde Park NY 11040-2529 Ph: (718) 343-7600 | Wilbert B. Maniego, M.d., P.c. 915 Hillside Ave New Hyde Park NY 11040-2529 Ph: (718) 343-7600 |
| NPI Number | 1295032753 |
|---|---|
| Provider Enumeration Date | 02/18/2011 |
| Last Update Date | 03/19/2012 |
| Medicare PECOS PAC ID | 1456510171 |
|---|---|
| Medicare Enrollment ID | O20120315000166 |
News Archive
Soligenix, Inc., formerly known as DOR BioPharma, Inc., a late-stage biotechnology company, announced today that it has initiated a Phase 1/2 clinical trial evaluating SGX201, a time-release formulation of oral beclomethasone 17,21-dipropionate (oral BDP), for the prevention of acute radiation enteritis.
Masimo, the inventor of Pulse CO-Oximetry™ and Measure-Through Motion and Low Perfusion pulse oximetry, announced today that a new independent study demonstrating the clinical accuracy of Masimo noninvasive and continuous hemoglobin (SpHb) monitoring was presented this week at the European Society of Anaesthesiology (ESA) Annual Congress in Helsinki, Finland.
Factors such as age at menopause as well as a woman's breastfeeding practices can influence her risk of developing certain types of breast cancer. That was the conclusion of a new study published in the October 1, 2008 issue of CANCER, a peer-reviewed journal of the American Cancer Society. The study's results suggest that there are distinct and separate hormonal risk factors associated with different subtypes of breast cancer.
In a review published in the April issue of Immunity, Kevin J. Tracey, MD, president of The Feinstein Institute for Medical Research, says it's time to take a fresh look at the medical community's approach to treating sepsis, which kills millions worldwide every year, including more than 200,000 Americans.
The diagnostic value of CT enteroclysis is superior to conventional enteroclysis, previously considered the gold standard, as an imaging method for the evaluation of the small bowel in patients with Crohn's disease, a new study shows.
› Verified 5 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1295032753 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | 221557 (New York) | Secondary |
| 207RG0300X | Internal Medicine - Geriatric Medicine | 221557-1 (New York) | Primary |
| Provider Name | Wilbert Maniego |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1356392427 PECOS PAC ID: 5496736753 Enrollment ID: I20040525000361 |
News Archive
Soligenix, Inc., formerly known as DOR BioPharma, Inc., a late-stage biotechnology company, announced today that it has initiated a Phase 1/2 clinical trial evaluating SGX201, a time-release formulation of oral beclomethasone 17,21-dipropionate (oral BDP), for the prevention of acute radiation enteritis.
Masimo, the inventor of Pulse CO-Oximetry™ and Measure-Through Motion and Low Perfusion pulse oximetry, announced today that a new independent study demonstrating the clinical accuracy of Masimo noninvasive and continuous hemoglobin (SpHb) monitoring was presented this week at the European Society of Anaesthesiology (ESA) Annual Congress in Helsinki, Finland.
Factors such as age at menopause as well as a woman's breastfeeding practices can influence her risk of developing certain types of breast cancer. That was the conclusion of a new study published in the October 1, 2008 issue of CANCER, a peer-reviewed journal of the American Cancer Society. The study's results suggest that there are distinct and separate hormonal risk factors associated with different subtypes of breast cancer.
In a review published in the April issue of Immunity, Kevin J. Tracey, MD, president of The Feinstein Institute for Medical Research, says it's time to take a fresh look at the medical community's approach to treating sepsis, which kills millions worldwide every year, including more than 200,000 Americans.
The diagnostic value of CT enteroclysis is superior to conventional enteroclysis, previously considered the gold standard, as an imaging method for the evaluation of the small bowel in patients with Crohn's disease, a new study shows.
› Verified 5 days ago
News Archive
Soligenix, Inc., formerly known as DOR BioPharma, Inc., a late-stage biotechnology company, announced today that it has initiated a Phase 1/2 clinical trial evaluating SGX201, a time-release formulation of oral beclomethasone 17,21-dipropionate (oral BDP), for the prevention of acute radiation enteritis.
Masimo, the inventor of Pulse CO-Oximetry™ and Measure-Through Motion and Low Perfusion pulse oximetry, announced today that a new independent study demonstrating the clinical accuracy of Masimo noninvasive and continuous hemoglobin (SpHb) monitoring was presented this week at the European Society of Anaesthesiology (ESA) Annual Congress in Helsinki, Finland.
Factors such as age at menopause as well as a woman's breastfeeding practices can influence her risk of developing certain types of breast cancer. That was the conclusion of a new study published in the October 1, 2008 issue of CANCER, a peer-reviewed journal of the American Cancer Society. The study's results suggest that there are distinct and separate hormonal risk factors associated with different subtypes of breast cancer.
In a review published in the April issue of Immunity, Kevin J. Tracey, MD, president of The Feinstein Institute for Medical Research, says it's time to take a fresh look at the medical community's approach to treating sepsis, which kills millions worldwide every year, including more than 200,000 Americans.
The diagnostic value of CT enteroclysis is superior to conventional enteroclysis, previously considered the gold standard, as an imaging method for the evaluation of the small bowel in patients with Crohn's disease, a new study shows.
› Verified 5 days ago
Robert Glaser M.d. P.c. Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 1 Hollow Ln, Suite 312, New Hyde Park, NY 11042 Phone: 516-328-3888 Fax: 516-487-0576 | |
Marie Elena Dragonetti Do Pc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 1300 Union Tpke, Suite 207, New Hyde Park, NY 11040 Phone: 516-488-3100 Fax: 516-488-3110 | |
Select Physicians, Pc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 410 Lakeville Rd Ste 200, New Hyde Park, NY 11042 Phone: 516-488-9700 Fax: 516-488-5128 | |
Thomas P Mathew Md Pc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 915 Hillside Ave, New Hyde Park, NY 11040 Phone: 718-343-7600 Fax: 718-343-7603 | |
Bharathi Reddy Md Pc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 38 Duke Dr, New Hyde Park, NY 11040 Phone: 347-743-9519 | |
Baljit Kaur Medical Pllc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 5 Howard Ave, New Hyde Park, NY 11040 Phone: 516-849-8235 | |
Asadur Miah Physician Pc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 1575 Hillside Ave, Suite 201, New Hyde Park, NY 11040 Phone: 516-775-7112 Fax: 516-775-9019 |